본문

ScienceON 검색

ScienceON '특허' 검색

더보기
국가과학기술정보센터(ScienceON) 특허검색
No 제목 / 내용
1 우수한 트레드 마모 / 히스테리시스 성능을 나타내는 카본블랙 / 캐보트 코포레이션
약90-98m2의 CTAB, 약92-102m2/g 의 N2SA, 90-98m2/g의 I2가, 약126-136cc/100g의 DBP, 약 102-100cc/100의 ODPH 및 약104-112틴트를 갖는 카본 블랙
2 우수한 트레드 마모/히스테리시스 성능을 나타내는카본 블랙을함유하는 고무조성물 / 캐보트 코포레이션
본 발명은 약 90-98 m2/g의 CTAB, 약 92-102 m2/g의 N2SA, 90-98 m2/g의 I2가, 약 126-136 cc/100g의 DBP, 약 102-110 cc/100g의 CDBP, 약 104-112의 틴트를 갖는 우수한 트레드 마모/히스테리시스의 카본 블랙에 관한 것이다. 또한, 우수한 트레드 마모/히스테리시스 성능 특성을 나타내는 카본 블랙을 함유하는 고무 조성물도 기재되어 있다.
3 송신 장치, 수신 장치, 송신 방법 및 수신 방법 / 선 페이턴트 트러스트
ePDCCH에 있어서 크로스 캐리어 스케줄링을 적절히 행할 수 있는 송신 장치.이 장치에 있어서, 설정부(102)는, 복수의 컴포넌트 캐리어(CC:Component Carrier)를 이용해서 통신을 행할 때, 제 1 CC 내의 데이터 할당 가능 영역에 포함되는, 복수의 할당 단위군 중 동일한 할당 단위군 내에, 제 1 CC용 제어 정보를 할당하는 후보인 제 1 서치 스페이스와, 복수의 CC 중의 제 1 CC 이외의 제 2 CC용 제어 정보를 할당하는 후보인 제 2 서치 스페이스를 설정하고, 송신부(106)는, 제 1 서치 스페이스 및 제 2 서치 스페이스 각각에 매핑된 제어 정보를 송신한다.
4 Carbon black exhibiting superior treadwear/hysteresis performance / Cabot Corporation (Boston MA 02)
Superior treadwear/hysteresis carbon blacks having a CTAB of about 90-98 m2/g, a N2SA of about 92-102 m2/g, an I2 No. of 90-98 m2/g, a DBP of about 126-136 cc/100 g, a CDBP of about 102-110 cc/100 g, and a Tint of about 104-112. Also disclosed are rubber compositions containing the carbon blacks which exhibit superior treadwear/hysteresis performance properties.
5 TERMINAL AND COMMUNICATION METHOD / NUNOME, Tomoya
Provided is a terminal which can suitably apply precoding to a PDCCH. In the terminal (100), when a first CC is notified of scheduling information for each of a first component carrier (CC) and a second CC, a restriction determination unit (105) determines, on the basis of a subcarrier interval of the CC to be scheduled by means of the scheduling information among the first CC and the second CC, the maximum number of blind decodings when the scheduling information is blind-decoded. An extraction unit (102) performs the blind decoding on the basis of the maximum number of blind decodings and extracts the scheduling information.
6 Terminal and communication method for blind-decoding scheduling information / Panasonic Intellectual Property Corporation of America
Provided is a terminal which can suitably apply precoding to a PDCCH. In the terminal (100), when a first CC is notified of scheduling information for each of a first component carrier (CC) and a second CC, a restriction determination unit (105) determines, on the basis of a subcarrier interval of the CC to be scheduled by means of the scheduling information among the first CC and the second CC, the maximum number of blind decodings when the scheduling information is blind-decoded. An extraction unit (102) performs the blind decoding on the basis of the maximum number of blind decodings and extracts the scheduling information.
7 TERMINAL AND COMMUNICATION METHOD FOR BLIND-DECODING SCHEDULING INFORMATION / NUNOME, Tomoya
Provided is a terminal which can suitably apply precoding to a PDCCH. In the terminal (100), when a first CC is notified of scheduling information for each of a first component carrier (CC) and a second CC, a restriction determination unit (105) determines, on the basis of a subcarrier interval of the CC to be scheduled by means of the scheduling information among the first CC and the second CC, the maximum number of blind decodings when the scheduling information is blind-decoded. An extraction unit (102) performs the blind decoding on the basis of the maximum number of blind decodings and extracts the scheduling information.
8 TRANSMITTING DEVICE AND TRANSMITTING METHOD / PANASONIC CORPORATION
A transmitting device and method enabling improvement of the reception quality on the receiving side when the LDPC-CC (Low-Density Parity-Check Convolutional Codes) encoding is used. The transmitting device (100) comprises an LDPC-CC encoding section (102), a sorting section (121) for sorting the encoded data (120) acquired by the LDPC-CC encoding section (102) into a first encoded data set (103_A) corresponding to the column number of the column containing “1” in a part of an LDPC-CC check matrix H from which a protograph is excluded and a second encoded data set (103_B) corresponding to the column numbers of the columns other than that, and a frame constructing section (a control section (106)) for constructing a transmission frame where the first and second encoded data sets (103_A, 103_B) are arranged in positions different in time or frequency in the transmission frame.
9 CIRCUIT FOR DETECTING REMAINING LIFE OF RECHARGEABLE BATTERY, ELECTRONIC APPARATUS AND AUTOMOBILE USING THE SAME, AND METHOD FOR DETECTING CHARGE STATE / ROHM CO LTD
PROBLEM TO BE SOLVED: To improve the method of detecting the SOC of a battery.SOLUTION: A remaining life detection circuit 200 detects the state of charge (SOC) of a rechargeable battery 102. A coulomb counter circuit 202 integrates the charge/discharge current IBAT of the battery 102 and generates a coulomb count value CC. A voltage detection circuit 204 detects the voltage VBAT of the battery 102. The SOC computation unit 206 calculates a raw SOC value SOC_cc on the basis of the coulomb count value CC. A discharge time correction unit 210 corrects the raw SOC value SOC_cc on the basis of a voltage drop of the battery 102 during a discharge of the battery 102 and generates a discharge time SOC value SOC_dis. A charge time correction unit 230 measures a lowest value SOC_dis_min which the discharge time SOC value SOC_dis reaches during a latest discharge of the battery 102, and calculates a charge time SOC value SOC_chg using the lowest value SOC_dis_min during a charge of the battery 102.SELECTED DRAWING: Figure 4
10 BASE STATION DEVICE, MOBILE STATION DEVICE, RADIO TRANSMITTING METHOD, AND RADIO RECEIVING METHOD / FUJITSU LTD
PROBLEM TO BE SOLVED: To allocate data to a suitable component carrier to improve a throughput.SOLUTION: In a base station 10, an LCH priority extraction part 101 extracts an LCH priority added to transmission data, the extracted LCH priority is output to an allocation CC determination part 102, the allocation CC determination part 102, on the basis of the LCH priority input from the LCH priority extraction part 101, determines a CC which allocates the transmission data, and controls frequency of a local signal generation part 106 in accordance with the allocation result. The allocation CC determination part 102 allocates data having a low LCH priority to a component carrier included in a high frequency band, while allocating the transmission data having a high LCH priority to the component carrier included in a low frequency band.

ScienceON '논문' 검색

더보기
ScienceON 논문 검색
No 제목 / 내용
1 Is adjuvant oxaliplatin (Ox) overutilized in colon cancer (CC)? 408 cases from the practices of 102 oncologists.
American Society of Clinical Oncology , 2013 ; Vol. 31 , Issue 4
2 Is adjuvant oxaliplatin (Ox) overutilized in colon cancer (CC): 408 cases from the practices of 102 oncologists.
American Society of Clinical Oncology , 2013 ; Vol. 31 , Issue 15
3 Common Law Remedies and Relational Contracting: <I>McNeil v Aberdeen CC (No 2)</I> [2013] CSIH 102
American Society of Clinical Oncology , 2014 ; Vol. 43 , Issue 2
4 Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study
Springer-Verlag , 2021 ; Vol. 26 , Issue 1
5 The CC genotype in the T102C HTR2A polymorphism predicts relapse in individuals after alcohol treatment
Pergamon Press , 2013 ; Vol. 47 , Issue 4
6 The CC genotype in HTR2A T102C polymorphism is associated with behavioral impulsivity in alcohol-dependent patients
Pergamon Press , 2012 ; Vol. 46 , Issue 1
7 The combination of TAS-102 and bevacizumab as the third-line chemotherapy for metastatic colorectal cancer (TAS-CC3 Study).
American Society of Clinical Oncology , 2019 ; Vol. 37 , Issue _suppl4
8 The combination of TAS-102 and bevacizumab as the third line chemotherapy for metastatic colorectal cancer (TAS-CC3 Study)
Elsevier , 2018 ; Vol. 29 , Issue 8
9 A phase II multicenter study of the chimeric monoclonal antibody NEO102 (N) in adults with refractory colorectal cancer (CC).
American Society of Clinical Oncology , 2015 ; Vol. 33 , Issue _suppl15
10 A phase I/II multicenter study of the chimeric monoclonal antibody NEO102 (NPC-1C) in adults with refractory pancreatic (PC) and colorectal cancer (CC).
American Society of Clinical Oncology , 2015 ; Vol. 33 , Issue 3

ScienceON '보고서' 검색

더보기

QuickMenu